New study paves the way for liver cirrhosis treatments New study paves the way for liver cirrhosis treatments The ADVANCE study will be the most detailed observational study of its kind providing a detailed analysis of liver health.
equine asthma equine asthma Fighting Equine Asthma is a crucial step to improving the well-being of many horses worldwide. The right treatment can make a world of difference.
Chronic kidney disease in cats Chronic kidney disease in cats Detect and manage chronic kidney disease and high blood pressure in cats
Promising phase II results in chronic kidney disease Promising phase II results in chronic kidney disease Boehringer Ingelheim’s investigation of novel compound on top of standard of care empagliflozin shows promising results for chronic kidney disease
Aftopor®/Aftovaxpur®/Aftovax® Aftopor®/Aftovaxpur®/Aftovax® FMD vaccines with highly potent and purified antigens (Aftopor®, Aftovaxpur®) allow differentiation between infected and vaccinated animals for endemic or emergency situations.
GPP: there is more than you see GPP: there is more than you see Generalized Pustular Psoriasis is a rare neutrophilic skin condition. Watch an animation to learn about its recurrent nature and how it affects people
Cooperation with The Defeat-NCD Partnership Cooperation with The Defeat-NCD Partnership Together with The Defeat-NCD Partnership, Boehringer Ingelheim aims to address key access to healthcare issues related to non-communicable diseases.
Central Nervous System Diseases Central Nervous System Diseases Find out more about our research and development in central nervous system diseases
Lady, a guide dog in the office Lady, a guide dog in the office A great partnership between a Boehringer Ingelheim employee and her guide dog at work. Their relationship goes beyond the human-animal bond.
Partnership canine oncology Partnership canine oncology The collaboration will focus on identifying new molecules to target cancers in dogs. Small molecules could provide superior disease control.
Boehringer Ingelheim announces collaboration with MabGenesis Boehringer Ingelheim announces collaboration with MabGenesis Boehringer Ingelheim announces collaboration with MabGenesis to discover and develop novel monoclonal antibodies in canine
First Translational Medicine Award awarded First Translational Medicine Award awarded The Award recognizes the research that has the highest translational potential
Blue internal teat sealant now in dairy mastitis portfolio Blue internal teat sealant now in dairy mastitis portfolio Boehringer Ingelheim adds blue internal teat sealant to its dairy mastitis portfolio
Positive opinion Ingelvac CircoFLEX and Ingelvac PRRSFLEX EU Positive opinion Ingelvac CircoFLEX and Ingelvac PRRSFLEX EU Boehringer Ingelheim receives positive opinion for the combined use of Ingelvac CircoFLEX® and Ingelvac PRRSFLEX EU® in the EU